Skip to content

H2020HORIZON

Imagine Institut des Maladies Genetiques Necker Enfants Malades Fondation

Country
FRFrance
Defence projects
0
Projects, all programmes
21
As coordinator
5
EU contribution (CORDIS)
EUR 9,218,686
Active
2016 to 2025

Projects

21 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
Cilia-AIEuropean Training Program for Deconvolution of Multi-scale Cilia Function in Health and Disease by Integrating Machine Learning-AI Approaches.HORIZON2025ParticipantEUR 565,387
InFlaMeCounter-acting the pandemic potential of flaviviruses: addressing virus-host interactions and defense strategies to design new therapeutics against WNV and DENVHORIZON2025ParticipantEUR 859,300
ERDERAEUROPEAN RARE DISEASES RESEARCH ALLIANCEHORIZON2024ParticipantEUR 236,212
LINMOSLineage tracing of the human brainHORIZON2024Third partyNot stated
TheRaCilTherapies for Renal CiliopathiesHORIZON2023CoordinatorEUR 1,989,483
REI_MSMDInborn errors of translation reinitiation in humans with Mendelian susceptibility to mycobacterial diseaseHORIZON2023CoordinatorEUR 211,755
EdiGenTNew Prime Editing and non-viral delivery strategies for Gene TherapyHORIZON2022ParticipantEUR 735,000
NADISNAD+ International Scientist-trainingHORIZON2022ParticipantEUR 260,471
EDITSCDAssessing efficacy and safety of genome EDITing approaches for Sickle Cell DiseaseHORIZON2022CoordinatorEUR 1,529,500
CHANGECellular Homeostasis ANd AGing in Connective TissuE DisordersHORIZON2022ParticipantEUR 282,694
NEUROTWINPromoting S&T excellence and increasing the innovation capacity of the Transylvanian Institute of NeuroscienceH20202021ParticipantEUR 81,250
MitoFeronMitochondrial integrity and autoinflammationH20202020CoordinatorEUR 184,708
SCilSStudying Ciliary Signaling in Development and DiseaseH20202020ParticipantEUR 549,604
BINDBrain Involvement iN DystrophinopathiesH20202020ParticipantEUR 165,585
HDM-FUNHost directed medicine in invasive fungal infectionH20202020ParticipantEUR 633,124
NEUcrestTraining European Experts in Multiscale Studies of Neural Crest Development and Disorders: from Patient to Model Systems and Back again.H20202019ParticipantEUR 274,802
SingCelCDSingle Cell approaches for the study of oncogenic processes during coeliac disease.H20202019CoordinatorEUR 196,708
EJP RDEuropean Joint Programme on Rare DiseasesH20202019ParticipantEUR 200,604
E-T1IFNsElaboration of the type I interferonopathiesH20202018ParticipantEUR 262,500
ALS-NetworksDefining functional networks of genetic causes for ALS and related neurodegenerative disordersH20202017Third partyNot stated

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.